Menstrual Disorders Practice Questions

Q: What is the best contraceptive option for managing menorrhagia?

Hormonal IUD. ***Hormonal IUD*** - The **levonorgestrel-releasing intrauterine device (LNG-IUD)** is highly effective for menorrhagia due to its localized release of progesterone, which thins the endometrial lining, significantly **reducing menstrual blood loss**. - It also provides highly effective, **long-acting contraception** while offering non-contraceptive benefits like menorrhagia management. *Non-hormonal IUD* - The **copper IUD** can actually **increase menstrual bleeding** and dysmenorrhea, which would worsen menorrhagia. - It works by inducing a local inflammatory reaction in the uterus to prevent fertilization and implantation, without hormonal effects on the endometrium. *Oral progestin* - While oral progestins can sometimes be used to manage menorrhagia, they are generally **less effective** than the hormonal IUD for long-term reduction in menstrual blood loss. - They require **daily adherence** and do not offer the same extended period of efficacy as the hormonal IUD. *Barrier contraceptives* - Barrier methods like **condoms or diaphragms** provide contraception by physically blocking sperm, but they have **no effect on menstrual bleeding** or menorrhagia. - They offer no therapeutic benefit for heavy menstrual bleeding and are solely contraceptive in function.

Q: Dysfunctional uterine bleeding (DUB) is best treated by:

Progestogen. ***Progestogen*** - **Progestogen** therapy helps stabilize the **endometrium**, reducing excessive or irregular bleeding in DUB by counteracting unopposed estrogen. - It induces a more organized shedding of the uterine lining, which can regularize the menstrual cycle. *Curettage of uterus* - While **curettage** can provide temporary relief by removing the endometrial lining, it is primarily a diagnostic procedure to rule out pathology rather than a primary long-term treatment for DUB. - It does not address the underlying hormonal imbalance that causes DUB, leading to a high recurrence rate of symptoms. *Estrogen* - **Estrogen** therapy alone is generally not used to treat DUB because unopposed estrogen is often the cause of DUB, leading to **endometrial overgrowth** and irregular shedding. - Administering estrogen without a progestin could exacerbate the condition and increase endometrial proliferation. *Clomiphene* - **Clomiphene** is an anti-estrogen medication primarily used to induce **ovulation** in women with infertility. - It is not indicated for the management of dysfunctional uterine bleeding or for regulating menstrual cycles directly.

Q: Menorrhagia is defined as:

Increased loss of blood than normal during menstruation. ***Increased loss of blood than normal during menstruation*** - **Menorrhagia** is specifically defined as **heavy or prolonged menstrual bleeding** that interferes with a woman's physical, emotional, social, and material quality of life. - This typically means a blood loss of more than 80 mL per cycle or menses lasting longer than 7 days, though a subjective assessment of excessive bleeding by the patient is also key. *Intermenstrual bleeding* - **Intermenstrual bleeding**, also known as metrorrhagia, refers to **bleeding that occurs between menstrual periods**. - It is distinct from menorrhagia, which concerns the characteristics of the menstrual period itself. *Menses occurring in less than 28 days* - This describes **polymenorrhea**, which is characterized by **frequent menstrual periods** (e.g., cycles shorter than 21 days). - While it can be associated with increased bleeding frequency, it does not directly define the volume or duration of blood loss like menorrhagia does. *Menses occurring more than 45 days apart* - This describes **oligomenorrhea**, which refers to **infrequent menstrual periods** (e.g., cycles longer than 35 days but less than 6 months). - It is the opposite of polymenorrhea and is not related to the excessive blood loss that defines menorrhagia.

Q: 22-year-old female comes to your outpatient department complaining of frequent periods, which occur every 18 days. What is this condition called?

Polymenorrhea. ***Polymenorrhea*** - This term describes **menstrual bleeding** that occurs **more frequently than normal**—specifically, an interval of **less than 21 days** between periods. - The patient's 18-day cycle falls within this definition, indicating abnormally frequent menstruation. *Menorrhagia* - **Menorrhagia** refers to **heavy or prolonged menstrual bleeding**, where the duration is typically more than 7 days or blood loss exceeds 80 mL. - It does not specifically describe the frequency of the periods. *Metrorrhagia* - **Metrorrhagia** is characterized by **irregular, acyclic bleeding** between menstrual periods, or bleeding that is not associated with the expected menstrual cycle. - This patient's periods are regular in their frequency, although too frequent, rather than irregular or intermenstrual. *Hypermenorrhea* - This term is often used interchangeably with **menorrhagia**, referring to **excessively heavy menstrual bleeding**. - It does not address the issue of the short interval between menstrual cycles.

Q: What is the average menstrual flow during normal menses?

30ml. ***30ml*** - The average menstrual blood loss during a normal period is approximately **30 mL**. - While there is a range, 30 mL is often cited as the mean for defining **normal menses**. *50ml* - Although it falls within the broader definition of normal, 50ml is slightly higher than the statistically observed **average menstrual flow**. - Blood loss exceeding **80 mL** is generally considered **menorrhagia**. *15ml* - A menstrual flow of **15 mL** is on the lower end of the normal range and could sometimes be indicative of **hypomenorrhea**. - While not necessarily abnormal, it is less common as an average compared to 30 mL. *80ml* - A menstrual flow of **80 mL** is consistently considered **menorrhagia** or heavy menstrual bleeding. - This level of blood loss can lead to **anemia** and often requires investigation and treatment.

Q: Which of the following conditions can contribute to congestive dysmenorrhea?

All of the options contribute to pelvic congestion. ***All of the options contribute to dysmenorrhea*** - **Congestive dysmenorrhea** is an older term referring to secondary dysmenorrhea associated with pelvic pathology and vascular congestion. All mentioned conditions can contribute to painful menstruation through various mechanisms. - These conditions represent causes of **secondary dysmenorrhea** (dysmenorrhea with underlying pelvic pathology). *Uterine fibroids causing dysmenorrhea* - **Uterine fibroids** (leiomyomas) cause dysmenorrhea through multiple mechanisms: increased prostaglandin production, uterine distension, and compromised blood flow. - Submucosal fibroids are particularly associated with **menorrhagia and dysmenorrhea** due to increased endometrial surface area and altered uterine contractility. - Large fibroids can cause pelvic heaviness and pressure symptoms. *Pelvic inflammatory disease causing dysmenorrhea* - **Pelvic inflammatory disease (PID)** causes chronic pelvic pain and dysmenorrhea through inflammation, adhesion formation, and tubo-ovarian pathology. - The resulting **chronic inflammation** and scarring can lead to persistent pelvic pain that worsens during menstruation. - PID is a common cause of secondary dysmenorrhea in reproductive-age women. *Intrauterine device (IUD) causing dysmenorrhea* - **Copper IUDs** are particularly associated with increased dysmenorrhea and menorrhagia due to local inflammatory response and increased prostaglandin production. - The foreign body reaction causes increased uterine contractility and cramping, especially in the first few months after insertion. - Levonorgestrel IUDs typically reduce dysmenorrhea rather than cause it.

Q: A 32-year-old woman presents with irregular, heavy menstrual bleeding. After thorough evaluation including pelvic ultrasound, hormonal assays, coagulation profile, and endometrial sampling, no structural abnormalities, systemic disorders, or medication-related causes are identified. This clinical scenario is best described as:

No identifiable causes present. ***No identifiable causes present*** - As per its definition, **dysfunctional uterine bleeding (DUB)** is diagnosed when no structural, systemic, or iatrogenic etiology for abnormal uterine bleeding can be found. - The diagnosis of DUB is essentially a **diagnosis of exclusion**, meaning it is made after ruling out other potential causes of bleeding. *Presence of systemic causes* - If systemic causes, such as **coagulation disorders** or **thyroid dysfunction**, are identified, the bleeding is attributed to these conditions, and it is not considered DUB. - DUB specifically implies that systemic factors have been investigated and found to be absent or not the primary cause of the bleeding. *Presence of iatrogenic causes* - **Iatrogenic causes** refer to abnormal bleeding induced by medical interventions, such as specific medications (e.g., anticoagulants, hormonal contraceptives) or medical devices (e.g., IUDs). - If such causes are identified, the bleeding is categorized accordingly, and the diagnosis of DUB is excluded. *Presence of identifiable organic causes* - **Organic causes** include structural abnormalities of the uterus or reproductive tract, such as **fibroids**, **polyps**, **adenomyosis**, or **malignancy**. - The presence of any of these identifiable pathology rules out DUB, as DUB is by definition non-organic.

Q: In a patient with secondary amenorrhea, failure to experience withdrawal bleeding after administration of estrogen and progesterone indicates dysfunction of which structure?

Endometrium. ***Endometrium*** - If the **endometrium** fails to respond to **estrogen and progesterone therapy**, it suggests a problem with the uterine lining itself, such as **Asherman's syndrome** or severe endometrial atrophy. - In such cases, despite adequate hormonal stimulation, there is **no withdrawal bleeding** because the target tissue (endometrium) cannot proliferate or shed. *Pituitary* - A **dysfunctional pituitary gland** would typically cause secondary amenorrhea by failing to produce adequate **gonadotropins (LH and FSH)**, which in turn leads to ovarian dysfunction. - However, in this scenario, if the pituitary were the primary issue, providing exogenous **estrogen and progesterone** would likely still induce withdrawal bleeding if the uterus is responsive. *Hypothalamus* - The **hypothalamus** controls pituitary function by releasing **GnRH**. Hypothalamic dysfunction (e.g., due to stress, extreme exercise, or weight loss) causes **hypogonadotropic hypogonadism**. - While it's a common cause of secondary amenorrhea, exogenous **estrogen and progesterone** should still induce withdrawal bleeding if the uterus is healthy and responsive. *Ovary* - **Ovarian failure** (e.g., premature ovarian insufficiency) leads to low **estrogen** and **high FSH/LH** levels. - If the ovaries are the cause, administering **estrogen and progesterone** would typically induce withdrawal bleeding because the uterus is usually functional and responsive to these hormones.

Question 1

What is the best contraceptive option for managing menorrhagia?

Accepted Answer

Hormonal IUD

Answer

Oral progestin

Answer

Non-hormonal IUD

Answer

Barrier contraceptives

Question 2

Dysfunctional uterine bleeding (DUB) is best treated by:

Accepted Answer

Progestogen

Answer

Curettage of uterus

Answer

Estrogen

Answer

Clomiphene

Question 3

Menorrhagia is defined as:

Accepted Answer

Increased loss of blood than normal during menstruation

Answer

Menses occurring in less than 28 days

Answer

Intermenstrual bleeding

Answer

Menses occurring more than 45 days apart

Question 4

22-year-old female comes to your outpatient department complaining of frequent periods, which occur every 18 days. What is this condition called?

Accepted Answer

Polymenorrhea

Answer

Metrorrhagia

Answer

Hypermenorrhea

Answer

Menorrhagia

Question 5

What is the average menstrual flow during normal menses?

Accepted Answer

30ml

Answer

80ml

Answer

15ml

Answer

50ml

Question 6

Which of the following conditions can contribute to congestive dysmenorrhea?

Accepted Answer

All of the options contribute to pelvic congestion

Answer

Uterine fibroids causing pelvic congestion

Answer

Pelvic inflammatory disease leading to inflammation

Answer

Intrauterine device (IUD) usage causing pelvic inflammation

Question 7

A 32-year-old woman presents with irregular, heavy menstrual bleeding. After thorough evaluation including pelvic ultrasound, hormonal assays, coagulation profile, and endometrial sampling, no structural abnormalities, systemic disorders, or medication-related causes are identified. This clinical scenario is best described as:

Accepted Answer

No identifiable causes present

Answer

Presence of systemic causes

Answer

Presence of iatrogenic causes

Answer

Presence of identifiable organic causes

Question 8

In a patient with secondary amenorrhea, failure to experience withdrawal bleeding after administration of estrogen and progesterone indicates dysfunction of which structure?

Accepted Answer

Endometrium

Answer

Pituitary

Answer

Hypothalamus

Answer

Ovary

Menstrual Disorders — MCQs

Menstrual Disorders — MCQs

On this page

Practice by Chapter

Want unlimited practice?